Acute myeloid leukemia in the elderly: Etoposide when anthracyclins are contraindicated

Leukemia and Lymphoma

Volumn 46, Issue 3, 2005, Pages 401-404

  Chaoui, Driss ^a   De Latour, Regis Peffault ^a   Legrand, Ollivier ^a   Marie, Jean Pierre ^a  

^a HÔTEL DIEU   (France)

Author keywords

Acute myeloid leukemia; Cardiac disease; Etoposide

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BLEEDING; BRAIN HEMORRHAGE; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG FATALITY; DRUG SAFETY; FEMALE; FRANCE; GERIATRIC PATIENT; HEART DISEASE; HEART FAILURE; HOSPITAL DEPARTMENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH HEMORRHAGE; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 13644269685     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400013134     Document Type: Article

References (13)

1. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051-1062.
2. Baudard M, Beauchamp-Nicoud A, Delmer A, Rio B, Blanc C, Marie JP et al. Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over 16-years-old. Leukemia 1999;13:1481-1490.
3. Baudard M, Marie JP, Cadiou M, Viguié F, Zittoun R. Acute myelogenous leukemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol 1994;86:82-91.
4. Bishop JF, Lowenthal R, Joshua D, Matthews JP, Wolf MM, Cooper IA. Etoposide in leukemia. Cancer 1991;67(Suppl. 1):285-291.
5. Grimwalde D, Walker H, Oliver F, Wheatley K, Harrison H, Rees J et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322-2333.
6. Rowe JM. Treatment of acute myelogenous leukemia in older adults. Leukemia 2000;14:480-487.
7. Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukemia in patients over 55-years-old: a population based study of incidence, treatment and outcome. Leukemia 1995;9:231-237.
8. Lowenberg B, Sucieu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R et al. Mitoxantrone versus daunorubicin in induction and consolidation therapy: the value of low-dose cytarabine for maintenance remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report of the Leukemia Organization for the Research and Treatment of Cancer and the Dutch-Belgium Hemato-Oncology Cooperative Hovon Group Randomised Phase III Study AML9. J Clin Oncol 1998;16:872-880.
9. Gryn J, Conroy J, Topolsky D, Crilley P, Kahn SB, Bulova S et al. High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemia. Am J Clin Oncol 1991;14:52-54.
10. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K, Burnett AK, Goldstone AH. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001;98:312-320.
11. Legrand O, Perrot JY, Simonin G, Baudard M, Marie JP. JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 2001;97:502-508.
12. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood 1997;89:3323-3329.
13. Estey EH. How I treat older patients with AML. Blood 2000;96:1670-1673.